Budget Battles
-
Republicans Want Strings Attached to California Disaster Aid
-
Biden Goes Out With a Bang in the Jobs Market
-
Trump Privately Pushes Senators for ‘One Big, Beautiful Bill’
-
Trump Considers Declaring National Emergency for Tariff Rollout
-
Trump Unloads: Grievances, Greenland and the Gulf of Mexico
-
Republicans Divided Over How to Pass Trump’s Agenda
-
Trump Pushes Johnson to Victory as Speaker
-
The GOP Has One Last Health Care Plan. It Would Also Cause Millions to Lose Coverage
By Michael RaineyNow that Republicans have failed to pass multiple versions of health care bills to repeal and replace Obamacare, or just repeal it, there’s only one GOP health care bill left floating around: one...
-
A Growing List of Bipartisan Ideas for Fixing Obamacare
By Michael RaineyThe failure of the most recent Republican attempt to repeal and replace the Affordable Care means that Obamacare will likely be with us for the foreseeable future. This political reality has given a...
-
What Can Be Done About Rising Drug Prices?
Republican efforts to repeal and replace Obamacare may have collapsed, but as Northern Trust economists Carl R. Tannenbaum and Ankit Mital wrote in a note published Friday , there’s a broader...
-
Why Republicans Can’t Cure Their Obamacare Hangover
With repeal and replace dead at the moment, Republicans in Congress and in the White House now have to make a choice in how to deal with Obamacare. Do they attempt to manage it as best as possible,...
-
Obamacare Premiums and Budget Deficits Will Soar If Trump Ends Insurer Subsidies
By Rob GarverIf the Trump administration follows through on its threat to stop paying insurance companies a controversial set of subsidies established by the Affordable Care Act, the government will lose money...
-
One More Try? Why Obamacare Repeal Is on the Horizon Again
By Rob GarverThe effort to repeal and replace the Affordable Care Act, which many assumed was dead or at least in a state of suspended animation for the foreseeable future, may be showing some stirring of life...
-
Taxpayers Will Pay the Price for Uncertainty Over Obamacare in 2018
By Rob GarverOn average, the amount of premium payment picked up by the federal government will increase by about 63 percent in the states reviewed by the Kaiser Family Foundation.
-
Here’s Medicare for All: Long Wait Times, Fewer Doctors, and Huge Tax Hikes
Fresh off his surprisingly close challenge of Hillary Clinton in the 2016 primaries – and her ignominious defeat in the general election – Bernie Sanders has emerged as the leader of progressive...
-
Heads Up: Health Care Is Still in Trouble
By Rob GarverThe issue of the US health insurance system was taken off the front burner with the evident failure of the Republican effort to repeal and replace the Affordable Care Act. But while it may not be in...
-
Here’s How Much More Your Health Insurance Will Cost Next Year
Consumers who get health insurance through their jobs won’t see rate hikes in the double digits like those on the Obamacare exchanges, but they’ll still see the cost of health care go up.
-
China culls birds as flu deaths mount; airline shares fall
By Fayen Wong and Clare Baldwin, ReutersSHANGHAI/HONG KONG (Reuters) - Chinese authorities slaughtered over 20,000 birds at a poultry market in Shanghai on Friday as the death toll from a new strain of bird flu mounted to six, spreading...
-
Obama May Already Be a Lame Duck President
By Josh Boak and Eric Pianin, The Fiscal TimesIs it possible that little more than two months after his second inauguration, President Obama is beginning to run low on juice? His favorability is sagging. The progressive agenda he touted has...
-
Big Pharma Stung by Landmark Patent Defeat in India
By BEN HIRSCHLER and KAUSTUBH LULKAMI, ReutersThe decision by India's Supreme Court on Monday not to allow a patent on Novartis AG's cancer drug Glivec angered but did not surprise U.S. and European drug companies, given past intellectual...
-
Exclusive - Pfizer, Novartis, Abbott weigh bids for Brazil's Ache - sources
By Jessica Toonkel and Ben Hirschler, ReutersNEW YORK/LONDON (Reuters) - At least three of the world's top drugmakers are bidding for Brazil's Ache Laboratorios Farmaceuticos in an auction that may value the group at more than $5 billion,...
-
Analysis: Big Pharma down, not out, after Indian patent blow
By Ben Hirschler and Kaustubh Kulkarni, ReutersLONDON/MUMBAI (Reuters) - Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country tipped to be the world's...